Regulatory Issues

Interoperability and the Connected Health Care System

By Chiquita Brooks-LaSure – The COVID-19 pandemic exposed many shortcomings in our health care system, especially the ability to quickly share and use reliable data to better understand the health needs of all people across the country. This need for more accessible data is why CMS remains committed to making health care data flow more freely…

Read More



HHS Priorities for 2022

Looking at 2022 the HHS reported its regulatory and deregulatory rule proposals for inclusion in the Administrations unified agenda released in December. We take a look at the ONC, CMS, and HRSA agencies under HHS.


CMS Seeking Recommendations for MIPS Specialty Measure Sets

CMS is accepting stakeholders’ recommendations regarding potential new specialty measure sets and/or revisions to existing specialty measure sets for the 2023 performance year of MIPS. Recommendations for new specialty sets or revisions to the 2022 specialty sets should be based on the established 2022 MIPS quality measures.



Pharmacy Interoperability Challenges and Needs Under the 21st Century Cures Act

By Jason Ausili PharmD – As interoperability provisions from the Cures Act enter their enforcement phase, pharmacy leaders within the Pharmacy HIT Collaborative, the U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology, and pharmacy system vendors, met recently to discuss the state of pharmacy interoperability.